Background
School: Tel Aviv University
Degree: MD
School: New York University School of Medicine
Graduated: 2019
Degree: Addiction Psychiatry Residency Program
NPI Number
1205249331
HIPAA Compliant or conform to confidentiality agreement/NDA?
Yes
Payment & Insurance
Accepted Insurance Plans
- Aetna
- BlueCross and BlueShield
- UnitedHealthcare
Accepting new clients?
Yes
More information & resources
In 2020 Dr. Reiff was lead author on an important article in Psychedelics and Psychedelic-Assisted Psychotherapy:
Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM; the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research. Psychedelics and Psychedelic-Assisted Psychotherapy. Am J Psychiatry. 2020 May 1;177(5):391-410. doi: 10.1176/appi.ajp.2019.19010035. Epub 2020 Feb 26. PMID: 32098487.
The authors provide an evidenced-based summary of the literature on the clinical application of psychedelic drugs in psychiatric disorders.
Other articles by Dr. Reiff'are listed on his website.
